This site is part of the Siconnects Division of Sciinov Group
This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.
ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
Matthew Phillips is a full-time neurologist based in Waikato Hospital, Hamilton, New Zealand. His main interest is to explore the role of dietary modification, particularly ketogenic diets, as potential therapies in a variety of neurological disorders. In 2017, his team completed the world’s first randomized controlled study to involve a ketogenic diet in people with Parkinson’s disease, recently published in the journal Movement Disorders. In 2019, his team will conduct a similar randomized controlled study in people with Alzheimer’s disease.